Search
  • Philip Hockberger

Northwestern’s Chemistry of Life Processes Institute Hatches IPO of the Decade

January 28, 2020 - What happens when a highly interdisciplinary and integrated team of scientists, business leaders and students work together across fields of fundamental science, discovery, development, and finance? In the case of Monopar Therapeutics, a Chemistry of Life Processes Institute-affiliated spin-out, it leads to a record-breaking initial public offering.


Last month, Monopar (MNPR), a clinical stage biopharmaceutical company that develops proprietary therapeutics for cancer, experienced the “best first-day pop for an IPO since Baidu in 2005,” according to Nasdaq News. The company’s stock price rocketed 231 percent from its initial offering, reaching a market valuation of $289 million on its first day.


For more information, click here.

0 views

Chicago Biomedical Innovation Alliance

© 2019 by Philip Hockberger

Created using Wix.com

633 Clark St, Crown North Tower, room 2-543, Evanston, IL 60208

Email: p-hockberger@northwestern.edu

Tel: 847-467-1509